Literature DB >> 8414642

Suppression of Schistosoma bovis egg production in cattle by vaccination with either glutathione S-transferase or keyhole limpet haemocyanin.

H O Bushara1, M E Bashir, K H Malik, M M Mukhtar, F Trottein, A Capron, M G Taylor.   

Abstract

Two of the antigens which have shown vaccine potential in animal experiments against Schistosoma mansoni are glutathione-S-transferase (GST) and GP38, protective epitopes of which are shared with keyhole limpet haemocyanin (KLH). We therefore tested S. bovis GST and KLH for vaccine efficacy against S. bovis in the natural Zebu cattle host. In a preliminary experiment three vaccinations with a total of 1.39 mg of native GSTs of S. bovis induced specific antibody at the time of challenge as detected by Western blotting and ELISA and mean faecal egg counts between weeks 6-10 post-challenge were reduced by 56.4 to 82.5% compared to non-vaccinated controls. Mean adult worm recoveries and tissue egg densities in large intestine and liver samples were also reduced in the vaccinated group, but these differences were not statistically significant. In a subsequent experiment one group of calves was vaccinated with a similar schedule to that used above; a second group of calves was given only two injections of GST (total 0.48 mg protein); a third group of calves was vaccinated twice with a total of 2.0 mg KLH in PBS. All three vaccination schedules induced specific antibody. Both GST vaccination schedules induced significant reductions in faecal egg counts compared to non-vaccinated controls and in this experiment tissue egg densities were also significantly reduced. A striking finding, however, was that adult worm counts were not reduced by vaccination. An essentially similar outcome resulted from KLH vaccination, since there were significant reductions in faecal and tissue egg counts in the absence of a reduction in adult worm numbers.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414642     DOI: 10.1111/j.1365-3024.1993.tb00623.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  12 in total

1.  Immunization with Wuchereria bancrofti Glutathione-S-transferase Elicits a Mixed Th1/Th2 Type of Protective Immune Response Against Filarial Infection in Mastomys.

Authors:  Dhananjay Andure; Kiran Pote; Vishal Khatri; Nitin Amdare; Ramchandra Padalkar; Maryada Venkata Rami Reddy
Journal:  Indian J Clin Biochem       Date:  2016-02-09

2.  Relationship of impairment of schistosome 28-kilodalton glutathione S-transferase (GST) activity to expression of immunity to Schistosoma mattheei in calves vaccinated with recombinant Schistosoma bovis 28-kilodalton GST.

Authors:  J M Grzych; J De Bont; J Liu; J L Neyrinck; J Fontaine; J Vercruysse; A Capron
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  The effect of multiple transfers of immune serum on maturing Schistosoma bovis infections in calves.

Authors:  H O Bushara; O H Omer; K H Malik; M G Taylor
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

4.  Specific antibody responses to three schistosome-related carbohydrate structures in recently exposed immigrants and established residents in an area of Schistosoma mansoni endemicity.

Authors:  Cynthia W A Naus; Alexandra van Remoortere; John H Ouma; Gachuhi Kimani; David W Dunne; Johannis P Kamerling; André M Deelder; Cornelis H Hokke
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

5.  Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella.

Authors:  C M Khan; B Villarreal-Ramos; R J Pierce; G Riveau; R Demarco de Hormaeche; H McNeill; T Ali; N Fairweather; S Chatfield; A Capron
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  Immunogenicity of genetically engineered glutathione S-transferase fusion proteins containing a T-cell epitope from diphtheria toxin.

Authors:  S Pillai; K Dermody; B Metcalf
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

Review 7.  Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs?

Authors:  Daniel G Colley; Tamara S Andros; Carl H Campbell
Journal:  Infect Dis Poverty       Date:  2017-03-22       Impact factor: 4.520

8.  Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.

Authors:  Anandharaman Veerapathran; Gajalakshmi Dakshinamoorthy; Munirathinam Gnanasekar; Maryada Venkata Rami Reddy; Ramaswamy Kalyanasundaram
Journal:  PLoS Negl Trop Dis       Date:  2009-06-09

9.  Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment.

Authors:  Claire D Bourke; Norman Nausch; Nadine Rujeni; Laura J Appleby; François Trottein; Nicholas Midzi; Takafira Mduluza; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2014-05-08

10.  Human Schistosoma haematobium antifecundity immunity is dependent on transmission intensity and associated with immunoglobulin G1 to worm-derived antigens.

Authors:  Shona Wilson; Frances M Jones; Govert J van Dam; Paul L A M Corstjens; Gilles Riveau; Colin M Fitzsimmons; Moussa Sacko; Birgitte J Vennervald; David W Dunne
Journal:  J Infect Dis       Date:  2014-07-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.